Loading stock data…
$0.75+0.07 (+10.26%)
Lakewood-Amedex Biotherapeutics, Inc.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|
| Total Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -$886,750↓ | -$712,060↑ | -$1.88M↓ | -$542,609↑ | -$862,176 |
| Net Income | -$923,291↓ | -$744,918↑ | -$1.91M↓ | -$539,617↑ | -$854,539 |
Lakewood-Amedex Biotherapeutics, Inc. operates as a clinical-stage biotechnology company that develops antimicrobial products in the United States. The company offers products from its Bisphosphocin class, a novel class of antimicrobial agents a broa...